EFOCEA
Live / Applied — Third extension granted (statement of use) (as of 13 Mar 2026)
What this means for you
Not registered yet, but its 12 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98596906
- Mark type
- Stylized text
- Filed
- 12 Jun 2024
- Published for opposition
- 15 Oct 2024
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for complement-mediated diseases, addiction and oncology, none of the foregoing in connection with pharmaceutical preparations for the treatment of dermatological diseases and conditions
Owner
- Omeros Corporation, Seattle, WA, US
- Omeros Corporation, Seattle, WA, US
Prosecution history
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2026 — SOU EXTENSION 3 GRANTED
- 12 Mar 2026 — SOU EXTENSION 3 FILED
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Nov 2025 — SOU EXTENSION 2 GRANTED
- 07 Nov 2025 — SOU EXTENSION 2 FILED
- 07 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Apr 2025 — SOU EXTENSION 1 GRANTED
- 07 Apr 2025 — SOU EXTENSION 1 FILED
- 07 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2024 — PUBLISHED FOR OPPOSITION